TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis

Relationship with clinical characteristics

Hiroshi Matsushita, Yasuhiro Miyake, Akinobu Takaki, Tetsuya Yasunaka, Kazuko Koike, Fusao Ikeda, Hidenori Shiraha, Kazuhiro Nouso, Kazuhide Yamamoto

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background and Aim: Inappropriate innate immune responses have been suggested to contribute to the pathogenesis of primary sclerosing cholangitis (PSC). We evaluated the associations of expressions of toll-like receptor (TLR) 4, TLR9, and nucleotide-binding oligomerization domain-containing protein (NOD)-like receptor family pyrin domain containing 3 (NLRP3) in the biliary epithelial cells (BECs) with clinical features of PSC patients. Methods: We retrospectively evaluated the expressions of TLR4, TLR9, and NLRP3 in the intrahepatic BECs by immunohistochemical staining in 21 PSC patients and 10 normal controls. In PSC, 17 patients underwent liver biopsy, and, in the other four patients, liver specimens were obtained at the time of liver transplantation. Results: TLR9 expressions in BECs were higher in PSC patients than in normal controls. TLR9 expressions were correlated with Ludwig fibrosis scores in PSC patients. TLR4 and NLRP3 expressions were similar between PSC patients and normal controls. Seventeen PSC patients undergoing liver biopsy were followed up during a median period of 55.7 months. Four reached to liver transplantation and four developed cholangiocarcinoma. Patients developing cholangiocarcinoma showed lower NLRP3 expressions than the others. Patients reaching to liver transplantation showed higher TLR9 expressions. Expression levels of TLR9 and NLRP3 were not correlated with liver biochemical tests and Mayo risk scores. Conclusions: In PSC, excessive immune responses through TLR9 signaling may be associated with the disease progression. Insufficient immune response through NLRP3 signaling may be associated with the development of cholangiocarcinoma. Evaluation of TLR9 and NLRP3 expressions in BECs may be useful for predicting the prognosis as an auxiliary marker.

Original languageEnglish
Pages (from-to)600-608
Number of pages9
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume30
Issue number3
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Sclerosing Cholangitis
Epithelial Cells
Cholangiocarcinoma
Liver Transplantation
Liver
NLR Proteins
Pyrin Domain
Biopsy
Toll-Like Receptor 4
Innate Immunity
Disease Progression
Fibrosis
Nucleotides
Staining and Labeling

Keywords

  • Biliary epithelial cell
  • Cholangiocarcinoma
  • Inflammasome
  • Innate immunity
  • Primary sclerosing cholangitis
  • Toll-like receptor

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology
  • Medicine(all)

Cite this

TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis : Relationship with clinical characteristics. / Matsushita, Hiroshi; Miyake, Yasuhiro; Takaki, Akinobu; Yasunaka, Tetsuya; Koike, Kazuko; Ikeda, Fusao; Shiraha, Hidenori; Nouso, Kazuhiro; Yamamoto, Kazuhide.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 30, No. 3, 01.03.2015, p. 600-608.

Research output: Contribution to journalArticle

@article{0f303aa637ad45ee87fef730f64dc22e,
title = "TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: Relationship with clinical characteristics",
abstract = "Background and Aim: Inappropriate innate immune responses have been suggested to contribute to the pathogenesis of primary sclerosing cholangitis (PSC). We evaluated the associations of expressions of toll-like receptor (TLR) 4, TLR9, and nucleotide-binding oligomerization domain-containing protein (NOD)-like receptor family pyrin domain containing 3 (NLRP3) in the biliary epithelial cells (BECs) with clinical features of PSC patients. Methods: We retrospectively evaluated the expressions of TLR4, TLR9, and NLRP3 in the intrahepatic BECs by immunohistochemical staining in 21 PSC patients and 10 normal controls. In PSC, 17 patients underwent liver biopsy, and, in the other four patients, liver specimens were obtained at the time of liver transplantation. Results: TLR9 expressions in BECs were higher in PSC patients than in normal controls. TLR9 expressions were correlated with Ludwig fibrosis scores in PSC patients. TLR4 and NLRP3 expressions were similar between PSC patients and normal controls. Seventeen PSC patients undergoing liver biopsy were followed up during a median period of 55.7 months. Four reached to liver transplantation and four developed cholangiocarcinoma. Patients developing cholangiocarcinoma showed lower NLRP3 expressions than the others. Patients reaching to liver transplantation showed higher TLR9 expressions. Expression levels of TLR9 and NLRP3 were not correlated with liver biochemical tests and Mayo risk scores. Conclusions: In PSC, excessive immune responses through TLR9 signaling may be associated with the disease progression. Insufficient immune response through NLRP3 signaling may be associated with the development of cholangiocarcinoma. Evaluation of TLR9 and NLRP3 expressions in BECs may be useful for predicting the prognosis as an auxiliary marker.",
keywords = "Biliary epithelial cell, Cholangiocarcinoma, Inflammasome, Innate immunity, Primary sclerosing cholangitis, Toll-like receptor",
author = "Hiroshi Matsushita and Yasuhiro Miyake and Akinobu Takaki and Tetsuya Yasunaka and Kazuko Koike and Fusao Ikeda and Hidenori Shiraha and Kazuhiro Nouso and Kazuhide Yamamoto",
year = "2015",
month = "3",
day = "1",
doi = "10.1111/jgh.12711",
language = "English",
volume = "30",
pages = "600--608",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis

T2 - Relationship with clinical characteristics

AU - Matsushita, Hiroshi

AU - Miyake, Yasuhiro

AU - Takaki, Akinobu

AU - Yasunaka, Tetsuya

AU - Koike, Kazuko

AU - Ikeda, Fusao

AU - Shiraha, Hidenori

AU - Nouso, Kazuhiro

AU - Yamamoto, Kazuhide

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background and Aim: Inappropriate innate immune responses have been suggested to contribute to the pathogenesis of primary sclerosing cholangitis (PSC). We evaluated the associations of expressions of toll-like receptor (TLR) 4, TLR9, and nucleotide-binding oligomerization domain-containing protein (NOD)-like receptor family pyrin domain containing 3 (NLRP3) in the biliary epithelial cells (BECs) with clinical features of PSC patients. Methods: We retrospectively evaluated the expressions of TLR4, TLR9, and NLRP3 in the intrahepatic BECs by immunohistochemical staining in 21 PSC patients and 10 normal controls. In PSC, 17 patients underwent liver biopsy, and, in the other four patients, liver specimens were obtained at the time of liver transplantation. Results: TLR9 expressions in BECs were higher in PSC patients than in normal controls. TLR9 expressions were correlated with Ludwig fibrosis scores in PSC patients. TLR4 and NLRP3 expressions were similar between PSC patients and normal controls. Seventeen PSC patients undergoing liver biopsy were followed up during a median period of 55.7 months. Four reached to liver transplantation and four developed cholangiocarcinoma. Patients developing cholangiocarcinoma showed lower NLRP3 expressions than the others. Patients reaching to liver transplantation showed higher TLR9 expressions. Expression levels of TLR9 and NLRP3 were not correlated with liver biochemical tests and Mayo risk scores. Conclusions: In PSC, excessive immune responses through TLR9 signaling may be associated with the disease progression. Insufficient immune response through NLRP3 signaling may be associated with the development of cholangiocarcinoma. Evaluation of TLR9 and NLRP3 expressions in BECs may be useful for predicting the prognosis as an auxiliary marker.

AB - Background and Aim: Inappropriate innate immune responses have been suggested to contribute to the pathogenesis of primary sclerosing cholangitis (PSC). We evaluated the associations of expressions of toll-like receptor (TLR) 4, TLR9, and nucleotide-binding oligomerization domain-containing protein (NOD)-like receptor family pyrin domain containing 3 (NLRP3) in the biliary epithelial cells (BECs) with clinical features of PSC patients. Methods: We retrospectively evaluated the expressions of TLR4, TLR9, and NLRP3 in the intrahepatic BECs by immunohistochemical staining in 21 PSC patients and 10 normal controls. In PSC, 17 patients underwent liver biopsy, and, in the other four patients, liver specimens were obtained at the time of liver transplantation. Results: TLR9 expressions in BECs were higher in PSC patients than in normal controls. TLR9 expressions were correlated with Ludwig fibrosis scores in PSC patients. TLR4 and NLRP3 expressions were similar between PSC patients and normal controls. Seventeen PSC patients undergoing liver biopsy were followed up during a median period of 55.7 months. Four reached to liver transplantation and four developed cholangiocarcinoma. Patients developing cholangiocarcinoma showed lower NLRP3 expressions than the others. Patients reaching to liver transplantation showed higher TLR9 expressions. Expression levels of TLR9 and NLRP3 were not correlated with liver biochemical tests and Mayo risk scores. Conclusions: In PSC, excessive immune responses through TLR9 signaling may be associated with the disease progression. Insufficient immune response through NLRP3 signaling may be associated with the development of cholangiocarcinoma. Evaluation of TLR9 and NLRP3 expressions in BECs may be useful for predicting the prognosis as an auxiliary marker.

KW - Biliary epithelial cell

KW - Cholangiocarcinoma

KW - Inflammasome

KW - Innate immunity

KW - Primary sclerosing cholangitis

KW - Toll-like receptor

UR - http://www.scopus.com/inward/record.url?scp=84923249916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923249916&partnerID=8YFLogxK

U2 - 10.1111/jgh.12711

DO - 10.1111/jgh.12711

M3 - Article

VL - 30

SP - 600

EP - 608

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 3

ER -